Doshi Dipal
SEC CIK 1613084 · EDGAR
BoughtSold
Most active insiders at TRDA, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | PARMAR KUSH | Dir, 10% | — | $3.65M |
| 2 | MPM BIOVENTURES 2018, L.P. | 10% | — | $3.60M |
| 3 | MPM BioVentures 2014, L.P. | 10% | — | $3.60M |
| 4 | 5AM Ventures V, L.P. | 10% | — | $3.00M |
| 5 | Baker Bros. Advisors (GP) LLC | 10% | $1.35M | — |
| 6 | WENTWORTH KORY JAMES | CFO | — | $433.6K |
| 7 | Dowden Nathan J | Pres, COO | — | $425.7K |
| 8 | Sethuraman Natarajan | Pres, Research, Develop | — | $398.8K |
| 9 | BAKER FELIX | 10% | $261.8K | — |
| 10 | Zeiher Bernhardt G | Dir | $29.3K | — |
| 11 | Doshi Dipal | CEO, Dir | — | — |
Transactions 46
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-09-03 17:19 | 2026-09-02 | TRDA | Entrada Therapeutics, Inc. | Doshi Dipal | CEO, Dir | F - Tax | $7.14 | -8,724 | 517.3K | -2% | -$62.3K | |
| D | 2026-03-03 | 2026-03-01 | TRDA | Entrada Therapeutics, Inc. | Doshi Dipal | CEO, Dir | A - Grant | $0.00 | +139.4K | 555.1K | +34% | $0 |
| DM | 2026-03-03 | 2026-03-02+ | TRDA | Entrada Therapeutics, Inc. | Doshi Dipal | CEO, Dir | F - Tax | $11.73 | -29.1K | 526.0K | -5% | -$340.6K |
| 2026-02-06 | 2026-02-05 | AZTA | Azenta, Inc. | Doshi Dipal | Dir | A - Grant | $27.85 | +5,663 | 9,703 | +140% | +$157.7K | |
| 2025-09-04 | 2025-09-02 | TRDA | Entrada Therapeutics, Inc. | Doshi Dipal | CEO, Dir | F - Tax | $5.43 | -8,723 | 415.7K | -2% | -$47.4K | |
| D | 2025-03-04 | 2025-03-03 | TRDA | Entrada Therapeutics, Inc. | Doshi Dipal | CEO, Dir | F - Tax | $11.68 | -17.6K | 424.4K | -4% | -$205.2K |
| D | 2025-03-04 | 2025-03-01 | TRDA | Entrada Therapeutics, Inc. | Doshi Dipal | CEO, Dir | A - Grant | $0.00 | +116.2K | 442.0K | +36% | $0 |
| 2025-02-11 | 2025-02-07 | AZTA | Azenta, Inc. | Doshi Dipal | Dir | A - Grant | $52.32 | +4,040 | 4,040 | New | +$211.4K | |
| M | 2024-09-05 | 2024-09-03+ | TRDA | Entrada Therapeutics, Inc. | Doshi Dipal | CEO, Dir | F - Tax | $15.63 | -8,722 | 332.1K | -3% | -$136.3K |
| M | 2024-07-16 | 2024-07-12+ | TRDA | Entrada Therapeutics, Inc. | Doshi Dipal | CEO, Dir | S - Sale | $17.84 | -1,900 | 334.5K | -0.6% | -$33.9K |
| 2024-06-14 | 2024-06-13 | TRDA | Entrada Therapeutics, Inc. | Doshi Dipal | CEO, Dir | S - Sale | $16.17 | -1,000 | 336.4K | -0.3% | -$16.2K | |
| M | 2024-05-20 | 2024-05-16+ | TRDA | Entrada Therapeutics, Inc. | Doshi Dipal | CEO, Dir | S - Sale | $15.04 | -3,000 | 337.4K | -0.9% | -$45.1K |
| D | 2024-03-05 | 2024-03-01 | TRDA | Entrada Therapeutics, Inc. | Doshi Dipal | CEO, Dir | A - Grant | $0.00 | +104.7K | 348.0K | +43% | $0 |
| DM | 2024-03-05 | 2024-03-04+ | TRDA | Entrada Therapeutics, Inc. | Doshi Dipal | CEO, Dir | F - Tax | $12.50 | -7,604 | 345.4K | -2% | -$95.1K |
| 2024-02-20 | 2024-02-15 | TRDA | Entrada Therapeutics, Inc. | Doshi Dipal | CEO, Dir | S - Sale | $15.00 | -1,000 | 243.3K | -0.4% | -$15.0K | |
| 2024-01-18 | 2024-01-16 | TRDA | Entrada Therapeutics, Inc. | Doshi Dipal | CEO, Dir | S - Sale | $15.99 | -1,000 | 244.3K | -0.4% | -$16.0K | |
| 2023-12-22 | 2023-12-20 | TRDA | Entrada Therapeutics, Inc. | Doshi Dipal | Pres, CEO, Dir | S - Sale | $15.00 | -1,000 | 245.3K | -0.4% | -$15.0K | |
| 2023-11-13 | 2023-11-13 | TRDA | Entrada Therapeutics, Inc. | Doshi Dipal | Pres, CEO, Dir | S - Sale | $16.23 | -1,000 | 246.3K | -0.4% | -$16.2K | |
| 2023-10-19 | 2023-10-17 | TRDA | Entrada Therapeutics, Inc. | Doshi Dipal | Pres, CEO, Dir | S - Sale | $15.00 | -1,000 | 247.3K | -0.4% | -$15.0K | |
| 2023-09-15 | 2023-09-13 | TRDA | Entrada Therapeutics, Inc. | Doshi Dipal | Pres, CEO, Dir | S - Sale | $15.00 | -1,000 | 248.3K | -0.4% | -$15.0K | |
| D | 2023-09-06 | 2023-09-05 | TRDA | Entrada Therapeutics, Inc. | Doshi Dipal | Pres, CEO, Dir | F - Tax | $14.46 | -1,440 | 249.3K | -0.6% | -$20.8K |
| D | 2023-09-06 | 2023-09-01 | TRDA | Entrada Therapeutics, Inc. | Doshi Dipal | Pres, CEO, Dir | A - Grant | $0.00 | +49.6K | 250.7K | +25% | $0 |
| 2023-08-16 | 2023-08-14 | TRDA | Entrada Therapeutics, Inc. | Doshi Dipal | Pres, CEO, Dir | S - Sale | $15.67 | -1,000 | 201.1K | -0.5% | -$15.7K | |
| 2023-05-01 | 2023-04-27 | TRDA | Entrada Therapeutics, Inc. | Doshi Dipal | Pres, CEO, Dir | S - Sale | $13.71 | -2,000 | 202.1K | -1.0% | -$27.4K | |
| 2023-04-19 | 2023-04-17 | TRDA | Entrada Therapeutics, Inc. | Doshi Dipal | Pres, CEO, Dir | S - Sale | $18.01 | -2,092 | 204.1K | -1% | -$37.7K | |
| DA | 2023-04-19 | 2023-03-01 | TRDA | Entrada Therapeutics, Inc. | Doshi Dipal | Pres, CEO, Dir | A - Grant | $0.00 | +49.6K | 206.2K | +32% | $0 |
| M | 2023-03-29 | 2023-03-27 | TRDA | Entrada Therapeutics, Inc. | Doshi Dipal | Pres, CEO, Dir | S - Sale | $14.72 | -2,000 | 256.0K | -0.8% | -$29.4K |
| D | 2023-03-03 | 2023-03-02 | TRDA | Entrada Therapeutics, Inc. | Doshi Dipal | Pres, CEO, Dir | F - Tax | $11.60 | -3,324 | 257.8K | -1% | -$38.6K |
| D | 2023-03-03 | 2023-03-01 | TRDA | Entrada Therapeutics, Inc. | Doshi Dipal | Pres, CEO, Dir | A - Grant | $0.00 | +99.3K | 261.1K | +61% | $0 |
| 2023-03-02 | 2023-02-28 | TRDA | Entrada Therapeutics, Inc. | Doshi Dipal | Pres, CEO, Dir | S - Sale | $12.00 | -2,000 | 161.8K | -1% | -$24.0K | |
| 2023-01-30 | 2023-01-27 | TRDA | Entrada Therapeutics, Inc. | Doshi Dipal | Pres, CEO, Dir | S - Sale | $12.00 | -2,000 | 163.8K | -1% | -$24.0K | |
| 2023-01-10 | 2023-01-09 | TRDA | Entrada Therapeutics, Inc. | Doshi Dipal | Pres, CEO, Dir | S - Sale | $15.02 | -2,410 | 165.8K | -1% | -$36.2K | |
| M | 2022-12-29 | 2022-12-27+ | TRDA | Entrada Therapeutics, Inc. | Doshi Dipal | Pres, CEO, Dir | S - Sale | $15.02 | -14.6K | 182.2K | -7% | -$219.1K |
| 2022-11-30 | 2022-11-28 | TRDA | Entrada Therapeutics, Inc. | Doshi Dipal | Pres, CEO, Dir | S - Sale | $13.91 | -2,000 | 182.8K | -1% | -$27.8K | |
| M | 2022-10-27 | 2022-10-25+ | TRDA | Entrada Therapeutics, Inc. | Doshi Dipal | Pres, CEO, Dir | S - Sale | $20.80 | -14.1K | 186.8K | -7% | -$292.5K |
| M | 2022-10-24 | 2022-10-20+ | TRDA | Entrada Therapeutics, Inc. | Doshi Dipal | Pres, CEO, Dir | S - Sale | $18.64 | -5,939 | 201.2K | -3% | -$110.7K |
| M | 2022-09-28 | 2022-09-26+ | TRDA | Entrada Therapeutics, Inc. | Doshi Dipal | Pres, CEO, Dir | S - Sale | $15.25 | -10.6K | 207.9K | -5% | -$161.4K |
| M | 2022-09-23 | 2022-09-21+ | TRDA | Entrada Therapeutics, Inc. | Doshi Dipal | Pres, CEO, Dir | S - Sale | $15.11 | -4,425 | 216.4K | -2% | -$66.9K |
| 2022-09-19 | 2022-09-15 | TRDA | Entrada Therapeutics, Inc. | Doshi Dipal | Pres, CEO, Dir | S - Sale | $15.04 | -200 | 219.8K | -0.1% | -$3,008 | |
| M | 2022-09-12 | 2022-09-08+ | TRDA | Entrada Therapeutics, Inc. | Doshi Dipal | Pres, CEO, Dir | S - Sale | $15.13 | -1,788 | 220.0K | -0.8% | -$27.0K |
| 2022-09-06 | 2022-09-01 | TRDA | Entrada Therapeutics, Inc. | Doshi Dipal | Pres, CEO, Dir | A - Grant | $0.00 | +15.1K | 221.8K | +7% | $0 | |
| M | 2022-08-31 | 2022-08-29+ | TRDA | Entrada Therapeutics, Inc. | Doshi Dipal | Pres, CEO, Dir | S - Sale | $12.72 | -2,000 | 206.9K | -1.0% | -$25.4K |
| 2022-07-29 | 2022-07-27 | TRDA | Entrada Therapeutics, Inc. | Doshi Dipal | Pres, CEO, Dir | S - Sale | $12.00 | -2,000 | 208.7K | -0.9% | -$24.0K | |
| 2022-06-29 | 2022-06-27 | TRDA | Entrada Therapeutics, Inc. | Doshi Dipal | Pres, CEO, Dir | S - Sale | $12.00 | -4,000 | 210.7K | -2% | -$48.0K | |
| D | 2022-03-03 | 2022-03-01 | TRDA | Entrada Therapeutics, Inc. | Doshi Dipal | Pres, CEO, Dir | A - Grant | $0.00 | +30.2K | 214.7K | +16% | $0 |
| D | 2022-01-18 | 2022-01-13 | TRDA | Entrada Therapeutics, Inc. | Doshi Dipal | Pres, CEO, Dir | M - OptEx | $1.74 | +10.0K | 184.5K | +6% | +$17.4K |
Purchase Sale Sale after option exercise All abbreviations